All Updates

All Updates

icon
Filter
M&A
Click Therapeutics acquires assets of Better Therapeutics for undisclosed sum
Mental Health Tech
May 22, 2024
Last week:
Geographic expansion
Partnerships
Lemonade partners with Homesite to expand home insurance services
InsurTech: Personal Lines
Jun 14, 2024
Funding
BayaniPay raises USD 3 million in seed funding to expand payment solutions
Neobanks
Jun 14, 2024
Partnerships
Carbonfuture and Swiss Re partner for long-term carbon removal through biochar
Carbon Management Software
Jun 13, 2024
Funding
Sidekick raises GBP 8.5 million in seed and debt funding to support expansion
Retail Trading Infrastructure
Jun 13, 2024
Partnerships
Climatiq and Epicor partner to reduce CO2 emissions in supply chains
Carbon Management Software
Jun 13, 2024
Product updates
EHang's pilotless eVTOL aircraft concludes first flight launch in Saudi Arabia
Passenger eVTOL Aircraft
Jun 13, 2024
Partnerships
Skyports partners with Unified Aviation to accelerate global network release
Passenger eVTOL Aircraft
Jun 13, 2024
Industry news
Partnerships
USSF chooses Blue Origin, SpaceX, and ULA for ~USD 5.6 billion Pentagon launch contracts
Space Travel and Exploration Tech
Jun 13, 2024
Funding
AnyCreek raises USD 1.8 million in seed funding to enhance platform and expand into new markets
Travel Tech
Jun 13, 2024
Funding
Zeta Labs raises USD 2.9 million in pre-seed funding to develop autonomous AI agent
Generative AI Applications
Jun 13, 2024
Mental Health Tech

Mental Health Tech

May 22, 2024

Click Therapeutics acquires assets of Better Therapeutics for undisclosed sum

M&A

  • Click Therapeutics, a mental-health-focused digital therapeutics provider, has acquired the assets of cardiometabolic digital therapeutic provider Better Therapeutics for an undisclosed sum. The assets acquired include Better Therapeutics' FDA-authorized prescription digital therapeutic for type 2 diabetes (AspyreRx - BT-001) and other assets related to the treatment of obesity, hypertension, and hyperlipidemia.

  • With the acquisition of Better Therapeutics' assets, Click Therapeutics plans to bolster its development efforts in obesity and cardiometabolic diseases. It aims to fuse AspyreRx's clinically validated digital behavioral therapy with Click's AI-enabled platform to enhance patient care and provider capabilities. Click Therapeutics believes that its drug-software combination products can elevate patient care, improve clinical outcomes, and deliver valuable real-world data insights for providers and payers.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.